Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Catharina M. Korse"'
Autor:
Daniëlle E. J. Starreveld, Laurien A. Daniels, Heiddis B. Valdimarsdottir, William H. Redd, Jessie L. de Geus, Sonia Ancoli-Israel, Susan Lutgendorf, Catharina M. Korse, Jacobien M. Kieffer, Flora E. van Leeuwen, Eveline M. A. Bleiker
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Cancer related fatigue (CRF) is one of the most prevalent and distressing long-term complaints reported by (non-) Hodgkin survivors. To date there has been no standard treatment for CRF in this population. A novel and promising ap
Externí odkaz:
https://doaj.org/article/afa86dd74ddf491a8c1e83ffca716c5b
Autor:
Catharina M. KORSE, Stefan HOLDENRIEDER, Xiuyi ZHI, Xiaotong ZAHNG, Ling QIU, Andrea GEISTANGER, Marcus-Rene LISY, Birgit WEHNL, Daan van den BROEK, José M. ESCUDERO, Jens STANDOP, Mu HU, Rafael MOLINA
Publikováno v:
Chinese Journal of Lung Cancer, Vol 20, Iss 8, Pp 568-577 (2017)
Externí odkaz:
https://doaj.org/article/5d8df451677041339a69b03a224dee64
Autor:
Mark J. C. van Treijen, Catharina M. Korse, Rachel S. van Leeuwaarde, Lisette J. Saveur, Menno R. Vriens, Wieke H. M. Verbeek, Margot E. T. Tesselaar, Gerlof D. Valk
Publikováno v:
Frontiers in Endocrinology, Vol 9 (2018)
Background: Available neuroendocrine biomarkers are considered to have insufficient accuracy to discriminate patients with gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) from healthy controls. Recent studies have demonstrated a potential r
Externí odkaz:
https://doaj.org/article/4dfd490fb0cd4cbeaeb0d07ae1133492
Autor:
Diane van der Woude, Theo Rispens, Catharina M Korse, Sjoerd H van der Burg, Ellen Kapiteijn, John B A G Haanen, Winan J van Houdt, Els M E Verdegaal, Marij J P Welters, Jessica S W Borgers, Tineke J van Wesemael, Johannes V van Thienen, Kyra A Gelderman, Dirk J A R Moes
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 6 (2024)
Introduction Treatment with the immune checkpoint inhibitor anti-programmed cell death protein-1 (PD-1) often causes immune-related adverse events (irAEs). Since irAEs resemble autoimmune diseases, autoantibodies might play a role and could potential
Externí odkaz:
https://doaj.org/article/9616b7f6fe8b499baab93acfee17c709
Autor:
Mark J C van Treijen, Catharina M Korse, Wieke H Verbeek, Margot E T Tesselaar, Gerlof D Valk
Publikováno v:
Endocrine Connections, Vol 11, Iss 10, Pp 1-12 (2022)
Objective: Up to now, serial NETest measurements in individuals assessing the disease course of gastroenteropancreatic neuroendocrine tumors (GEPNETs) at long-term follow-up and treatment response were not studied. Design: The study was a longitudina
Externí odkaz:
https://doaj.org/article/0a52c0ea1c9a45a8b31c3f40d1ebdd11
Autor:
Thomas Muley, Xiaotong Zhang, Stefan Holdenrieder, Catharina M Korse, Xiu-yi Zhi, Rafael Molina, Zhongjuan Liu, Gunther Hartmann, Michel M van den Heuvel, Kun Qian, Ramon Marrades, Christine Engel, Ying He, Birgit Wehnl, Farshid Dayyani, Felix Herth
Publikováno v:
Tumor Biology, Vol 42 (2020)
This study aimed to investigate whether changes in progastrin-releasing peptide (ProGRP) levels correlate with treatment response and can be used to optimize clinical management of patients with small-cell lung cancer. Patients with small-cell lung c
Externí odkaz:
https://doaj.org/article/de453d033ca24de7ad50985f43964c44
Autor:
Stefan Holdenrieder, Rafael Molina, Ling Qiu, Xiuyi Zhi, Sandra Rutz, Christine Engel, Pia Kasper-Sauer, Farshid Dayyani, Catharina M Korse
Publikováno v:
Tumor Biology, Vol 40 (2018)
In squamous cell carcinoma, squamous cell carcinoma antigen levels are often elevated. This multi-center study evaluated the technical performance of a new Elecsys ® squamous cell carcinoma assay, which measures serum squamous cell carcinoma antigen
Externí odkaz:
https://doaj.org/article/95824dabd5c74aadb716e6432116f6ec
Autor:
Rocio Garcia-Carbonero, Piero Ferolla, Marianne Pavel, Nicola Fazio, Martyn Caplin, C. Lombard-Bohas, Eric Lim, Andrea Frilling, J.-Y. Scoazec, Eric Baudin, Ulrich Knigge, P.L. Filosso, Alfredo Berruti, Dieter Hörsch, W. W. de Herder, Anders Sundin, Catharina M. Korse
Publikováno v:
Annals of Oncology, 32(4), 439-451. Elsevier Ltd.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06ba45042b9eb6e27e14546f5aebdf77
https://pure.eur.nl/en/publications/83564c94-4175-4310-b591-0b8741d65d4a
https://pure.eur.nl/en/publications/83564c94-4175-4310-b591-0b8741d65d4a
Autor:
Alfredo Berruti, W. W. de Herder, Eric Baudin, Rocio Garcia-Carbonero, Catharina M. Korse, Anders Sundin, A. Frilling, C. Lombard-Bohas, Marianne Pavel, Piero Ferolla, Dieter Hörsch, Nicola Fazio, Ulrich Knigge, P.L. Filosso, Martyn Caplin, J.-Y. Scoazec, Eric Lim
Publikováno v:
Annals of Oncology. 32:1453-1455
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a69175531d30d61c7a6a5194be900cad
https://doi.org/10.1016/j.annonc.2021.08.2150
https://doi.org/10.1016/j.annonc.2021.08.2150
Autor:
V M T de Jong, Alwin D. R. Huitema, B van Wijnen, Catharina M. Korse, M.A.C. Bruin, B. van Triest, D. Van Den Broek, Hilde Rosing, Sabine C. Linn, J. H. Beijnen
Publikováno v:
European Journal of Clinical Pharmacology
Purpose Olaparib is a poly (ADP-ribose) polymerase (PARP) inhibitor indicated for ovarian and metastatic breast cancer. Increased serum creatinine levels have been observed in patients taking olaparib, but the underlying mechanism is unknown. This st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ef3eee091fbe19ba190791ddc79d4b2
http://europepmc.org/articles/PMC7803870
http://europepmc.org/articles/PMC7803870